天海防務(300008.SZ):擬設立參股公司海上風電綜合服務公司
格隆匯12月30日丨天海防務(300008.SZ)公佈,根據公司戰略發展規劃及業務發展需要,為貫徹落實海洋強國、廣東省“海洋強省”戰略,廣東南油控股集團有限公司(簡稱“南油集團”)擬與天海融合防務裝備技術股份有限公司共同發起組建海上風電綜合服務公司,發揮各自在海洋經濟領域的產業基礎與優勢,培育發展海洋戰略性新興產業,開拓海上風電全生命週期綜合服務業務。
雙方擬共同設立廣東南油海融新能源科技有限公司(暫定名),註冊資本為11,500萬元人民幣,其中公司出資1,500萬元,佔總股本的13.04%;南油集團出資10,000萬元,佔總股本的86.96%,並擬與南油集團簽訂《合作經營協議》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.